Case Studies in Anal Cancer Prevention (Web)

A. Treponema pallidum (syphilis)B. GonorrheaC. ChlamydiaD. HPV (Human Papillomavirus)E. HSV (Herpes Simplex Virus)

Congratulations. The best choice is D. HPV is the most common STI worldwide and in the US. Most sexually active adults will get exposed to at least one type of HPV, which is why primary prevention with the 9-valent HPV vaccination is important—ideally before the onset of sexual activity (vaccine is FDA approved until age 45).

Sorry, the correct answer is D. HPV is the most common STI worldwide and in the US. Most sexually active adults will get exposed to at least one type of HPV, which is why primary prevention with the 9-valent HPV vaccination is important—ideally before the onset of sexual activity (vaccine is FDA approved until age 45).

A. Anal cytology aloneB. High-risk anal HPV testing aloneC. Combination of anal cytology and high-risk HPV testingD. All of the above

Congratulations. The best answer is D. According to the new IANS guidelines, acceptable anal cancer screening tools (beyond digital anorectal exam) are: anal cytology alone, anal high-risk HPV testing alone, anal cytology/hrHPV co-testing, anal cytology with hrHPV triage or anal hrHPV testing with cytology triage. The tools depend on a variety of local factors including HRA capacity, and availability of hrHPV testing.

Sorry, the best answer is D. According to the new IANS guidelines, acceptable anal cancer screening tools (beyond digital anorectal exam) are: anal cytology alone, anal high-risk HPV testing alone, anal cytology/hrHPV co-testing, anal cytology with hrHPV triage or anal hrHPV testing with cytology triage. The tools depend on a variety of local factors including HRA capacity, and availability of hrHPV testing.

A. The treatment eliminates all disease and also eradicates HPV; no further follow-up/HRA is needed.B. Follow-up is only needed if symptoms develop.C. Recurrent HSIL is common since HPV is not eradicated with treatment and close follow-up with surveillance HRAs is recommended.

Congratulations. The best answer is C. Anal HSIL recurrence is common after treatment since hrHPV typically is not eradicated with the treatment, and ongoing surveillance is indicated. Factors predicting recurrence include longitudinal anal infection with HPV type 16 as well as more numerous and larger index HSIL lesions.

Sorry, the best answer is C. Anal HSIL recurrence is common after treatment since hrHPV typically is not eradicated with the treatment, and ongoing surveillance is indicated. Factors predicting recurrence include longitudinal anal infection with HPV type 16 as well as more numerous and larger index HSIL lesions.

YesNoRemained the same

	Strongly Agree (5)	Agree (4)	Neutral (3)	Disagree (2)	Strongly Disagree (1)
The content covered was useful and relevant to my current or future scope of practice.
The activity was fair, balanced, and free of bias.
The activity improved my knowledge of this clinical issue.
The learning objectives for this activity were achieved.
I am better able to: Communicate/collaborate with other members of the care team on this issue.
I am better able to: Improve access to care and treatment for underrepresented patient groups or geographies because of what I learned.
The information learned during this activity will help improve my skills or judgment within the next six months.
The content was presented clearly.
The educational activity was well planned and presented.

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
I intend to: Modify/change my practice or the practice of my team based on this educational activity.
I intend to: Work with my team to create/revise protocols, policies, and/or procedures with my care team.
I intended to: Share what I learned with other members of my care team.
I intend to: Make changes in how I communicate with/educate my patients.
I intend to: Seek additional information on topics discussed during the activity.
On average, I utilized the patient treatment strategies described in this educational activity prior to my participation.

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
My office and practice systems can accommodate the above changes.
My patients can accommodate the above changes.
Patient access to the treatments provided will be a barrier to implementing the above changes.

	Excellent (5)	Good (4)	Acceptable (3)	Poor (2)	Very Poor (1)
Activity Rating

Please provide the following informaiton to receive your CME/CE Certificate.

Confirmation Emailexample@example.com

The certificate emails auto-generated by this form are blocked by comcast.net email addresses. Please use an alternate email address if possible, or contact CEServices@academycme.org after submitting your form. **

Street Address

Street Address Line 2

State / Province

Country

This educational activity was certified for a maximum of 1.0 AMA PRA Category 1 Credits(TM), 1.0 ANCC Contact Hours, 1.0 AAPA Category 1 CME credits, and 1.0 ACPE Contact Hours.

Case Studies in Anal Cancer Prevention

Assessment

Evaluation